SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
19-Feb-20 8:41 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 14-Feb-20 | Disposition (other) Duplicate | 300,000 | -- | -- | (100%) 300.0K to 0 | |
19-Feb-20 8:04 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 14-Feb-20 | Disposition (other) | 300,000 | -- | -- | (100%) 300.0K to 0 | |
19-Feb-20 8:41 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 14-Feb-20 | Disposition (other) Duplicate | -- | -- | -- | 0% -- | |
19-Feb-20 8:04 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 14-Feb-20 | Disposition (other) | -- | -- | -- | 0% -- | |
18-Sep-19 5:23 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 17-Sep-19 | Purchase | 9,000 | $2.65 | $23,850.00 | 2% 591.0K to 600.0K | |
18-Sep-19 5:23 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 17-Sep-19 | Purchase | -- | -- | -- | 0% 600.0K | |
18-Sep-19 5:23 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 16-Sep-19 | Purchase | -- | -- | -- | 0% 582.0K | |
18-Sep-19 5:23 PM View: | Armistice Capital, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 16-Sep-19 | Purchase | 9,183 | $2.48 | $22,773.80 | 2% 572.82K to 582.0K | |
27-Nov-17 7:45 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 23-Nov-17 | Purchase | 100,000 | $0.09 | $9,292.00 | 100% 0 to 100.0K | |
27-Nov-17 7:45 PM View: | Berholtz Randy EVP, Corporate Development | Innovus Pharmaceuticals, Inc. (NONE) | 22-Nov-17 | Purchase | 16,880 | $0.10 | $1,630.69 | 100% 0 to 16.88K | |
02-Dec-16 6:18 PM View: | Novalere Holdings, LLC 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 30-Nov-16 | Acquisition (other) | 12,808,800 | -- | -- | 100% 12.81M to 25.62M | |
31-Dec-15 1:12 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 30-Dec-15 | Gift | 2,949,140 | -- | -- | (100%) 2.95M to 0 | |
29-Jun-15 4:48 PM View: | Damaj Bassam PRESIDENT AND CEO Director 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 26-Jun-15 | Grant | 50 | $0.12 | $5.84 | < 1% 6.85M to 6.85M | |
06-Jan-15 4:48 PM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 02-Jan-15 | Grant | 18,750 | -- | -- | 2% 882.47K to 901.22K | |
06-Jan-15 4:50 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 02-Jan-15 | Grant | 37,500 | -- | -- | 2% 1.79M to 1.83M | |
06-Jan-15 4:52 PM View: | Mirza Ziad Director | Innovus Pharmaceuticals, Inc. (NONE) | 02-Jan-15 | Grant | 18,750 | -- | -- | 4% 455.73K to 474.48K | |
22-Dec-14 2:30 PM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 18-Dec-14 | Gift | 135,000 | -- | -- | (13%) 1.02M to 882.47K | |
03-Oct-14 9:11 AM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Oct-14 | Grant | 8,108 | -- | -- | < 1% 1.01M to 1.02M | |
03-Oct-14 9:14 AM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Oct-14 | Grant | 16,216 | -- | -- | < 1% 1.77M to 1.79M | |
03-Oct-14 9:09 AM View: | Mirza Ziad Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Oct-14 | Grant | 8,108 | -- | -- | 2% 447.63K to 455.73K | |
03-Jul-14 4:43 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Jul-14 | Grant | 22,222 | -- | -- | 1% 1.75M to 1.77M | |
03-Jul-14 4:39 PM View: | Mirza Ziad Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Jul-14 | Grant | 11,111 | -- | -- | 3% 436.51K to 447.63K | |
03-Jul-14 4:36 PM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Jul-14 | Grant | 11,111 | -- | -- | 1% 998.25K to 1.01M | |
02-Apr-14 7:38 PM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Apr-14 | Grant | 7,317 | -- | -- | < 1% 990.93K to 998.25K | |
02-Apr-14 3:49 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Apr-14 | Grant | 14,634 | -- | -- | < 1% 1.74M to 1.75M | |
02-Apr-14 5:56 PM View: | Mirza Ziad Director | Innovus Pharmaceuticals, Inc. (NONE) | 01-Apr-14 | Grant | 7,317 | -- | -- | 2% 429.2K to 436.51K | |
21-Feb-14 6:04 AM View: | Damaj Bassam President and CEO Director 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 19-Feb-14 | Conversion | 1,190,410 | -- | -- | 184% 647.25K to 1.84M | |
20-Feb-14 3:22 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 19-Feb-14 | Conversion | 228,268 | -- | -- | 15% 1.51M to 1.74M | |
20-Feb-14 3:21 PM View: | Mirza Ziad Director | Innovus Pharmaceuticals, Inc. (NONE) | 19-Feb-14 | Conversion | 14,601 | -- | -- | 4% 414.6K to 429.2K | |
20-Feb-14 3:22 PM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 19-Feb-14 | Conversion | 146,014 | -- | -- | 17% 844.91K to 990.93K | |
06-Feb-14 8:13 PM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 04-Feb-14 | Grant | 7,500 | -- | -- | < 1% 837.41K to 844.91K | |
06-Feb-14 8:10 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 04-Feb-14 | Grant | 15,000 | -- | -- | 1% 1.49M to 1.51M | |
06-Feb-14 8:15 PM View: | Mirza Ziad Director | Innovus Pharmaceuticals, Inc. (NONE) | 04-Feb-14 | Grant | 7,500 | -- | -- | 2% 407.1K to 414.6K | |
18-Oct-13 5:31 PM View: | Esber Henry Jemil Director | Innovus Pharmaceuticals, Inc. (NONE) | 16-Oct-13 | Grant | 3,750 | -- | -- | < 1% 1.49M to 1.49M | |
18-Oct-13 5:31 PM View: | Mirza Ziad Director | Innovus Pharmaceuticals, Inc. (NONE) | 16-Oct-13 | Grant | 3,750 | -- | -- | < 1% 403.35K to 407.1K | |
18-Oct-13 5:31 PM View: | Liu Vivian H Director | Innovus Pharmaceuticals, Inc. (NONE) | 16-Oct-13 | Grant | 3,750 | -- | -- | < 1% 833.66K to 837.41K | |
10-Feb-14 4:02 PM View: | Damaj Bassam President and CEO Director 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 09-Sep-13 | Gift | 20,000 | -- | -- | (3%) 667.25K to 647.25K | |
14-Jun-13 9:30 PM View: | Damaj Bassam President & CEO Director 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 12-Jun-13 | Purchase | 287,448 | $0.32 | $92,845.70 | 6% 4.76M to 5.05M | |
14-Jun-13 9:30 PM View: | Damaj Bassam President & CEO Director 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 12-Jun-13 | Purchase | 129,393 | $0.32 | $41,793.90 | 3% 5.05M to 5.18M | |
30-May-13 9:46 PM View: | Brown Morgan R See remarks | Innovus Pharmaceuticals, Inc. (NONE) | 28-May-13 | Grant | 750,000 | -- | -- | 100% 0 to 750.0K | |
05-Feb-13 5:14 PM View: | Damaj Bassam President and CEO Director 10% Owner | Innovus Pharmaceuticals, Inc. (NONE) | 02-Feb-13 | Purchase | 250,406 | $0.48 | $118,993.00 | 100% 0 to 250.41K |